Cypherpunk Technologies Inc. Logo

Cypherpunk Technologies Inc. (5MC)

FSX

Currency in EUR
1.15
+0.23 (+24.46%)

Real-time Data

06:00 AM

Day's Range

1.02
1.15

52 wk Range

0.0420
3.00

Overview - 5MC - Cypherpunk Technologies Inc.

Key Statistics

Valuation

Enterprise Value

99.40M

P/E (Trailing)

‪2.09‬

PEG Ratio

‪0.08‬

Price / Book

‪1.03‬

EV / EBITDA

‪-2.77‬

Profitability

Profit Margin

‪0.00%‬

Operating Margin

‪0.00%‬

Return on Assets

‪-13.79%‬

Return on Equity

‪-1.20%‬

Ownership

Shares Outstanding

93.92M

Float

75.06M

Held by Insiders

‪8.33%‬

Held by Institutions

‪36.68%‬

Price stats

Beta

‪0.06‬

50-Day Avg

‪0.5639‬

200-Day Avg

‪0.7812‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - 5MC - Cypherpunk Technologies Inc.

Peers - 5MC - Cypherpunk Technologies Inc.

Peer Comparison

Compared with companies in Asset Management listed on FSX.

Profile Summary - 5MC - Cypherpunk Technologies Inc.

About

Cypherpunk Technologies Inc. is a biopharmaceutical company focused on developing novel antibody therapies for cancer treatment, with a strategic emphasis on biomarker-targeted approaches. The company’s lead clinical-stage candidate, DKN-01, is a monoclonal antibody designed to inhibit Dickkopf-related protein 1 and…

SectorFinancial Services
IndustryAsset Management
Employees6
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.